z-logo
open-access-imgOpen Access
Dendrimers: A New Race of Pharmaceutical Nanocarriers
Author(s) -
Pooja Mittal,
Anjali Saharan,
Ravinder Verma,
Farag M. A. Altalbawy,
Mohammed Alfaidi,
Gaber ElSaber Batiha,
Wahida Akter,
Rupesh K. Gautam,
Md. Sahab Uddin,
Md. Sohanur Rahman
Publication year - 2021
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2021/8844030
Subject(s) - dendrimer , nanocarriers , drug delivery , nanotechnology , molecule , combinatorial chemistry , materials science , monomer , drug , chemistry , polymer , organic chemistry , polymer chemistry , biology , pharmacology
Dendrimers are nanosized, symmetrical molecules in which a small atom or group of atoms is surrounded by the symmetric branches known as dendrons. The structure of dendrimers possesses the greatest impact on their physical and chemical properties. They grow outwards from the core-shell which further reacts with monomers having one reactive or two dormant molecules. Dendrimers' unique characteristics such as hyperbranching, well-defined spherical structure, and high compatibility with the biological systems are responsible for their wide range of applications including medical and biomedical areas. Particularly, the dendrimers' three-dimensional structure can incorporate a wide variety of drugs to form biologically active drug conjugates. In this review, we focus on the synthesis, mechanism of drug encapsulations in dendrimers, and their wide applications in drug delivery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom